Global Automated and Rapid Microbiological Tests Industry (2018 to 2028) - Global Market Trajectory & Analytics -

DUBLIN--()--The "Automated and Rapid Microbiological Tests - Global Market Trajectory & Analytics" report has been added to's offering.

Amid the COVID-19 crisis and the looming economic recession, the Automated and Rapid Microbiological Tests market worldwide will grow by a projected US$2.5 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 5.8%. GC/CRT (Clinical), one of the segments analyzed and sized in this study, is forecast to grow at over 7% and reach a market size of US$1.2 Billion by the end of the analysis period.

An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The GC/CRT (Clinical) market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 4.6% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$75.6 Million to the region's size over the next 7 to 8 years. In addition, over US$73.4 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the GC/CRT (Clinical) segment will reach a market size of US$14.5 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Automated and Rapid Microbiological Tests market.

Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 9.6% over the next couple of years and add approximately US$675.6 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Automated and Rapid Microbiological Tests market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Key Topics Covered:




  • Global In-Vitro Diagnostics Market
  • Central Laboratories Dominate the Market
  • Immunochemistry - the Leading Segment
  • Recent Market Activity
  • Automated and Rapid Microbiological Tests Revolutionize Microbiological Testing
  • Evolutionary Battle against Microbes Drives Market Future
  • Automated Microbiological Tests: A Pesky Gray Area in the Clinical Diagnostics Market
  • Instant Detection of Pathogens - A New Epoch in the Fight for Survival
  • Traditional Rapid Microbiological Tests Make Way for New, Probe Tests
  • Emerging Markets Provide Tremendous Growth Opportunities
  • Clinical Applications
  • Non-Clinical Applications
  • A Holistic Peek into a Few Noteworthy Trends
  • The Evolution of Biotechnology - A Crucial Step Ahead in the Growing Popularity of Rapid Microbial Tests
  • Point-of-Care Rapid Microbiological Testing: Yet to Realize Its Full Potential
  • Global Competitor Market Shares
  • Automated and Rapid Microbiological Tests Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
  • Impact of Covid-19 and a Looming Global Recession


  • Abbott Laboratories (US)
  • Abbott Molecular, Inc. (US)
  • Alere Inc. (US)
  • Beckman Coulter, Inc. (US)
  • Becton Dickinson and Company (US)
  • bioMrieux SA (France)
  • bioMerieux, Inc. (US)
  • Bio-Rad Laboratories, Inc (US)
  • Cellabs Pty Ltd (Australia)
  • Cepheid Inc. (US)
  • CorisBioconcept SPRL (Belgium)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Hologic, Inc. (US)
  • MedMira Inc. (Canada)
  • Meridian Bioscience, Inc. (US)
  • OraSure Technologies, Inc. (US)
  • Orion Diagnostica Oy (Finland)
  • QIAGEN N.V. (The Netherlands)
  • Quidel Corporation (US)
  • Sekisui Diagnostics, LLC (US)
  • Siemens Healthcare GmbH (Germany)
  • Thermo Fisher Scientific Inc. (US)
  • Oxoid Limited (UK)


  • Increasing Incidence of Infectious Diseases - An Opportunity Indicator
  • Rising Healthcare Needs of Aging Global Population - A Growth Driver
  • The World is Ageing
  • Rising HIV Prevalence - A Key Opportunity Indicator
  • Some Significant HIV Statistics by Region: 2015
  • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
  • Ultra-Rapid HIV-Screening Tests put up a Strong Fight against HIV-Epidemic
  • Accuracy/Reliability of Home HIV Testing: A Bone of Contention
  • Increase in Healthcare Spending in Emerging Markets to Propel Demand
  • Rising Emphasis on Lab Automation to Augur Well for Market Growth
  • Greater Patient Awareness to Drive Growth
  • Advancements in Molecular Diagnostics - A Boon
  • Antibiotic Resistant Bacteria Throws the Spotlight on Microbial Testing
  • Influenza - Boosting Rapid Test Prospects
  • Select FDA-approved Rapid Detection Tests for Flu A&B: (2015)
  • Automated Blood Culture Systems: The Gold Standard in the Fight against Bacteremia
  • Automated Blood Culture Systems: The Gold Standard in the Fight against Bacteremia
  • Impact of Food Scares on Rapid Microbiological Tests Market
  • Stringent Norms Necessitate Microbial Food Safety Testing
  • Rapid Screening Gains Preference over Traditional Food Testing Procedures
  • Conventional Testing Continues to Dominate but Rapid Tests Making Inroads
  • Leading Food Processors Resort to Rapid Microbiological Testing
  • Food Packages of the Future Ingrained with Microbial Alert Systems
  • Poultry Industry Embraces Rapid Microbiological Testing Technologies
  • Rapid Microbiological Tests Gain Significance in the Pharma Industry
  • Key Advantages of Rapid Microbiological Tests for Pharma- In a Nutshell
  • Growth Direct System Creates Waves in Pharmaceutical Quality Control





For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900